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MEASUREMENT OF WHITE MATTER STRUCTURE CHANGES IN
AMYOTROPHIC LATERAL SCLEROSIS USING FRACTAL ANALYSIS

ZAO LIU

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is recognized as a motor neuron disorder
affecting the structure and function of the brain and neuromuscular system. Very little is
known, however, that the nervous system degeneration is dependent on disease
phenotypes of ALS. The purpose of this study was to determine the degree of brain white
matter (WM) structure degeneration in four ALS patient groups characterized by their
clinical

signs

and

neuroimaging

measurements.

Fractal

dimension

(FD)

of

three-dimensional (3D) brain WM images was quantitatively analyzed to evaluate the
WM structural complexity, including complexity levels of the WM skeleton, surface and
general structures in ALS patients and control subjects. A total of 100 participants were
assigned into five groups: ALS patients with frontotemporal dementia (ALS-FTD, n=20),
ALS patients with predominantly upper motor neuron (UMN) signs and hyperintensity
MRI signals on corticospinal tract (CST) (UMN-CST+, n=20), ALS patients with
predominantly UMN signs but without hyperintensity signal on CST (UMN-CST-, n=27),
ALS patients with an equal amount of UMN and lower motor neuron (LMN) signs
(ALS-classic, n=22), and a neurological control group (n=11).

IV

The brain was extracted

from head images by using the FSL package, and the WM was segmented from and the
brain images before being separate into WM images of the left and right hemispheres.
Subsequently, skeletons of the WM bundles were obtained using a 3-dimensional
thinning method. FD analysis was applied onto three forms of the WM structure: skeleton,
surface, and general structure. FD of the skeletons and general structure in ALS-FTD
patients was significantly smaller (P<0.05 – P<0.01) than the controls and UMN-CST+,
and ALS-classic patients. The FD of UMN-CST+ patients was significantly larger
(P<0.05 – P<0.01) than UMN-CST- and ALS-classic patients. These results suggest that
the complexity level of brain WM network is dependent on ALS disease phenotypes and
ALS patients with dementia suffer the worst brain WM structural degeneration.
Asymmetry of WM structure complexity between left and right hemispheres was
observed in ALS-FTD and ALS-classic patients. Analysis of the whole brain WM
structure was more sensitive than that of either of the hemispheres with the skeleton
being the most sensitive structure for detecting degenerative changes. These findings
provided new information in better understanding ALS disease progression in the central
nervous system and for seeking effective treatments of this devastating disease.
Key Words: Amyotrophic lateral sclerosis (ALS), degeneration, white matter (WM),
fractal dimension (FD), skeleton, surface, general structure, magnetic resonance imaging
(MRI).
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CHAPTER I

INTRODUCTION AND BACKGROUND

1.1. Amyotrophic Lateral Sclerosis (ALS)
1.1.1. Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
that affects both upper motor neurons (UMNs) and lower motor neurons (LMNs).
Although the cause of ALS and related neural degeneration are not well understood, past
studies have shown that ALS patients suffer from behavioral dysfunction (Olney et al.,
2005), and some of them have cognitive impairment (Phukan et al., 2007) and encounter
depression and anxiety (Lou et al., 2003). Patients afflicted by ALS usually die within
five years mainly as a result of dysfunction of the respiratory system. This cruel disease
was first described by the French neurologist Jean-Martin Charcot in 1869 and did not
receive much national or international attention until Lou Gehrig, a star baseball player
with the New York Yankees, died of ALS in 1936. Therefore, ALS is also referred to as
“Lou Gehrig’s Disease”. The disease is relatively rare, occurring in only 2 of 100,000
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people each year (Logroscino et al., 2010). Currently, about 30,000 Americans have been
diagnosed with ALS, typically between the ages of 40and 70.
The name of Amyotrophic lateral sclerosis indicates that it is a neuron disease with
both upper and lower motor neuron signs. The Amyotrophic comes from the Greek
language, in which the A refers to no, the Myo means muscle and the Trophic identifies
nourishment. In whole, amyotrophic means no muscle nourishment and refers to muscle
atrophy, weakness, cramp and fasciculation, which are the signs of lower motor neuron
disease. The Lateral represents the areas in spinal cord where locates the nerve cells
innervate the muscles. When the lateral region degenerates, scarring or hardening,
referred to as Sclerosis, will occur (Rowland et al., 2001).
1.1.2. Motor Neuron Degeneration in ALS
The motor neurons provide control signals to skeletal muscles for voluntary
movements and muscle power. The degenerated motor neuron in ALS can no longer send
normal action potentials to muscle fibers innervated by the motor neurons. Consequently,
the corresponding muscle contractions are disrupted and the muscle atrophies, leading to
motor function disability. The degeneration of UMNs arises in the cerebral cortex, while
the degeneration of LMNs arises in the brainstem and spinal cord (Mitusmoto et al.,
1998).
Although the exact cause of ALS is still unknown, some emerging clues suggest
that excitotoxicity plays a critical role by damaging the motor neurons. It has been
reported that Glutamate (a potentially neuroexcitotoxic compound and neural transmitter
of the corticospinal system and certain spinal cord interneurons) is conformed to link
with the defect in the transport system in ALS patients (Plaitakis et al., 1987). To inhibit
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presynaptic release of glutamate, riluzole was first developed as an antiepileptic drug to
deal with ALS. However, riluzole canonly slow the course of ALS, whilst the long-term
ALS outcome is still the same.
1.2. Neuroanatomy
1.2.1. Neuron
Neurons are the main signaling units of the nervous system (Kandel et al., 2000).
Their functions are to sense any changes in environment, communicate those changes to
other neurons, and command body’s response to those sensations. A neuron consists of a
soma (cell body) and neuritis (axon and dendrites). The axons are wrapped in a sheath of
insulating lipoprotein called myelin to increase the signal conduction speed.
1.2.1.1. Upper Motor Neuron (UMN)
Upper motor neurons start in the motor cortex of brain (primarily in layer V of the
precentral gyrus) and terminate within the medulla or within the spinal cord (Figure 1.1);
they carry motor information down to the spinal cord, but they do not initiate the target
muscle directly. Betz cells are the main neurons for voluntary movement and are located
within layer V of the primary motor cortex, the internal pyramidal layer of the precentral
gyrus. These UMNs send long axons to the contralateral motor nuclei of the cranial
nerves (the lower motor neurons in the brain stem) and to the spinal nerves (the lower
motor neurons in the ventral horn of the spinal cord). These axons form the corticospinal
tract (CST).
1.2.1.2. Lower Motor Neuron (LMN)
LMNs are the motor neurons that connect the brainstem and spinal cord to the
muscle fibers that transfer the nerve impulses from the upper motor neurons to the
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muscles (Figure 1).
Lower motor neurons in the spinal cord innervate limb and body muscles and lie in
the ventral horn of the spinal cord. The axons these motor neurons bundle together to
form ventral roots, which join with a dorsal root to form a spinal nerve exiting the cord
through the notches between vertebrae. The motor neurons that project fibers to one
spinal nerve are said to belong to a spinal segment. The segments are named after the
vertebra where the nerve originates: cervical segments, thoracic segments, lumbar
segments, and sacral segments. Motor neurons located in different segments innervate
muscles in different body parts. For instance, spinal cord cervical segments contain the
motor neurons that innervate arm muscles, whilst spinal cord lumbar segments contain
the neurons that innervate leg muscles.
LMNs could be classified as alpha motor neurons and gamma motor neurons
according to the types of muscles which they innervate: Alpha motor neurons control
extrafusal muscle fibers, which are the most numerous type of muscle fiber and involved
in making joint movements. Gamma motor neurons control intrafusal muscle fibers,
which compose muscle spindles with sensory afferents indicating changes of muscle
length.
Alpha motor neurons generate and send control pulses to connected muscles that in
turn, make contraction and produce force and movement. Each alpha motor neuron
connects with a given number of muscle fibers through the motor axon. Sir Sherrington, a
well-known neurophysiologist and one of two Nobel Prize winners in physiology and
Medicine in 1932, termed this functional unit (motor neuron, its axon and all the
innervated muscle fibers) as a motor unit. The collection of all the alpha motor neurons
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that innervate one specific single muscle is called a motor neuron pool; all the muscle
contractions for this muscle are controlled by the individual or series of action potentials
from this motor neuron pool. To summarize, a motor unit contains an alpha motor neuron,
its axon and all muscle fibers it innervates; a motor neuron pool consists of all the alpha
motor neurons that innervate one single muscle.

Figure 1: UMN-CST-LMN neuron system. UMNs send long axons (CST) to the contralateral motor nuclei
of the cranial nerves (LMNs in the brain stem) and to the spinal nerves (LMNs in the ventral horn of the
spinal cord). (Rowland et al., 2001 with modified)

1.2.2. Corticospinal Tract (CST)
The brain communicates with the lower motor neurons in the spinal cord through
the axons descending from the brain to the spinal cord (Figure 1.1). Those axons form
two groups of pathways: lateral pathways, which are involved in voluntary movement of
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the distal musculature and are under direct cortical control; and ventromedial pathways,
which are involved in the control of posture and locomotion and are under both the brain
and brain stem control. The CST is the most important component of the lateral pathways,
which connects the UMNs and LMNs. Two-thirds of the axons in the CST start in areas 4
(primary motor cortex) and 6 (premotor and supplementary motor cortices) of the frontal
lobe, whilst most of the remaining axons derive from the somatosensory areas of the
parietal lobe and serve to regulate the flow of somatosensory information to the brain
(Bear et al., 2001).
Axons of the CST originating from the cortex pass through the internal capsule
(bridging the telencephalon and thalamus), the base of the cerebral peduncle (a large
collection of axons in the midbrain), the pons, and then collectively to form a tract at the
base of the medulla. Figure 2 shows the DTI of CST in three evaluated levels: the corona
radiate, the internal capsule, and the pons. The CST is consisted of two separate tracts in
the spinal cord: the lateral CST and anterior CST. Approximately 80% of the CST fibers
cross over to the contralateral side in the medulla oblongata (pyramidal decussation),
traveling in the lateral CST; ~10% of the fibers enter the lateral CST on the same side;
and the remaining 10% of the fibers cross over at the level that they exit the spinal cord,
traveling in the anterior corticospinal tract.
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Figure 2: MR diffusion tensor imaging (DTI) of the three evaluated levels of the cortiocpinal tract: (i)
corona radiate, (ii) internal capsule, and (iii) pons. Corticospinal tract is marked with blue in each level.
(Karlsborg et al., 2004)

1.2.3. White Matter (WM)
The white matter (WM) is one of the two most important components of the central
nervous system and consists mostly of myelinated axons, compared with gray matter
(GM), which contains cell bodies of neurons. It is white because the outer layer (myelin)
is a fatty substance. WM as a tissue functions primarily with conducting impulses from
one population of neurons (grey matter [GM]) to another. The CST is part of the WM
system that caries information from GM of sensorimotor areas in the cerebral cortex to
motor neurons in the brain stem and spinal cord.
There are three different tracts contained in the WM system: (i) projection tracts,

7

which send impulses from the cortex to other brain regions, and to nuclei in brain stem
and spinal cord, or from sensory receptor to the brain; (ii) commissural tracts, which pass
action potentials between left and right hemispheres of the brain through commissures;
and (iii) association tracts, which carry information between lobes within a single
hemisphere. The CST belongs to the projection tracts.

1.3. White Matter in ALS
1.3.1. Overview
At a microscopic level, ALS is demonstrated by axonal swelling with
neurofilament accumulations, axonal Wallerian degeneration and dendrites attenuation
(Cluskey and Ramsden, 2001). At a macroscopic level, the changes reflect the
microscopic changes indeed, such as axon degeneration (Metwalli et al., 2010) and
demyeliniztion.
1.3.2. Imaging of White Matter Changes in ALS
The diagnosis of ALS requires the presence of both UMN degeneration signs
(weakness, wasting and fasciculation) and LMN degeneration signs (increased or clonic
tendon reflexes, spasticity, pseudobulbar features, Hoffmann reflex and extensor plantar
response). To provide reliable criteria for ALS diagnosis, the E1 Escorial Criteria for
therapeutic trials were developed by medical and research experts in ALS associated with
the World Federation of Neurology (Brooks et al., 2000). However, the criteria are
considered too restrictive; some patients presumably died from ALS are not diagnosed as
an ALS patient. Genetic testing is not a routine evaluation unless there is a family history
of ALS.
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Magnetic Resonance Imaging (MRI) is an ideal method for diagnosis of UMN
signs because it is noninvasive and can provide different contrasts between different
tissues, which could detect the abnormities in ALS that could not be detected by other
devices, such as computed tomography (CT) (Mitusmoto et al., 1998). One previously
used MRI technique for detecting UMN abnormalities in ALS is measurement of image
signal intensity of the CST. Abnormal bilateral hyperintensity in the posterior portion of
the posterior limb of CST in the internal capsule in T2-weighted image was demonstrated
to relate to the degeneration of CST (Yagishita et al., 1994). Other MRI approaches, such
as evaluation of global cerebral atrophy both in motor and extra-motor areas using
T1-weighted images (Kassubek et al., 2005) and estimating WM integrity using diffusion
tensor imaging (DTI) (Graham et al., 2004) have been reported to be useful as
quantitative tools for monitoring progression of UMN pathology in longitudinal studies.

1.4. Skeleton
The concept of skeleton was introduced by Blum in 1967. Skeleton, also called
topological skeleton, is the thin version of object that is equidistant to its boundaries. In
other words, skeleton is the medial axis of that object. It defines an object geometrically,
summarizes the topological properties (connectivity, topology, size, shape and orientation)
of that object, and reserves all the information needed to reconstruct the original object.
In a two-dimensional brain image, skeleton is the one-pixel width central line within a
WM fiber bundle; in a three-dimensional brain image, it is a one-voxel width central line
within the fiber bundle. In this research, skeletons were extracted from brain WM
structures in ALS patients and control subjects because the medial axis can preserve the
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topological properties and the connectivity of the WM tracts/fiber bundles.
Physiologically, extracted skeletons represent complexity of the WM connectivity
network, such as fiber crossings and bifurcations. The method used for extracting WM
skeletons and their analysis has previously been described (Zhang et al. 2005). Brain WM
skeleton, surface (reflecting WM surface convolution), and general structure (showing
entire shape of the WM structure) were three forms of the WM structure evaluated in this
study.
1.5. Fractal Dimension
1.5.1. Fraction Dimension Definition
Dimension is the number of variables in a dynamic system. In Euclidean space,
there are three dimensions: D=1, D=2, and D=3.
Fractal Dimension is also called Hausdorff Dimension, which accurately measures
the dimension of irregular geometric objects, for example fractals.
In the Euclidean space, amplifying a one-dimensional line twice will obtain two
identical line segments; four identical squares are seen if a two-dimensional square is
amplified by two; eight three-dimensional cubes are obtained with the magnification of
two. Figure 3 demonstrates the magnification procedure.
According to the examples mentioned above, the relationship between the
magnification and dimension could be express by the Eq.1.1.
eD  N

(1.1)

In this equation, e is magnification, N is number of copies, and D is dimension. The
dimension could be obtained by taking the natural logarithm of both sides of Eq.1.1 as
Eq.1.2.
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D

ln N
ln e

(1.2)

Both Eq.1.1 and Eq.1.2 could also be applied to Fraction Dimension.
1.5.2. Measurement of Fractal Dimension
There are several methods to calculating FD, such as the box-counting method, the
correlation dimension method, etc. When estimating the image FD, the box-counting
method is preferred, because it can apply on the target with or without self-similarity. It
works by repeatedly covering the different-sized box (r) onto the fractal and counting the
number of boxes (N) needed to completely cover the fractal (Figure 4A, B). In Figure 4,
two meshes with different sized box (5-pixel and 15-pixel) were overlaid onto a
two-dimensional (2D) WM binary image. For these two meshes, 1286 5-pixel-boxes
(Figure 4A) and 197 15-pixel-boxes (Figure 4B) covered all the WM structure
completely.
The FD could be defined in the power-law relationship (Eq.1.3)
N  kr  FD

(1.3)

The FD was obtained by linear fitting the Eq.1.4.
1
ln N  FD ln  ln k
r
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(1.4)

Figure 3: Illustration of relationship between dimension and magnification

(A)

(B)

Figure 4: Traditional 2D box-counting method, covering a 2D sample of binary WM slice with mesh with
different box sizes (r) and the number of boxes (N) needed to cover the whole WM structure completely
(green boxes in the images).
(A) r=5, N=1286 and (B) r=15, N=197. The images were generated by the box-counting package from
HarFA (http://www.fch.vutbr.cz/lectures/imagesci/) using data from one subject.
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1.5.3. Fractal Dimension Analysis Applied to Understand Brain WM Structure
Fractal dimension (FD) method is a promising method to evaluate condition of the
brain structure because it is not only sensitive in detecting brain WM degeneration in
normal aging, but also can notice the WM abnormalities due to pathological reasons.
Zhang et al. used FD to estimate age and gender effects on brain WM structure
complexity in healthy human subjects and found that the WM structural complexity
decreased with aging and this kind of deterioration is not uniformly distributed between
genders or across brain hemispheres (Zhang et al., 2007). The FD method was applied to
analysis of brain structures in multiple sclerosis (MS); significant changes of white matter
structure were identified (Francisco et al., 2007) along with abnormal morphology of GM
early in the course of MS disease (Francisco et al., 2009).

1.6. Thesis Objective and Organization
1.6.1. Rationale
It is well accepted that ALS is caused by structural and functional degenerations at
both UMN and LMN levels.

However, findings from previous research on this topic

were not consistent, sometimes even contradictory. One potential reason for this could be
that adaptations to ALS are dependent on disease phenotypes; one type of ALS may
affect the system more severely than the other. If this is true, investigating all types of
ALS patients as one condition may only yield minimal to moderate levels of alteration in
the hypothesized direction. Therefore, the major goal of this research was to evaluate
brain WM structural degeneration in four types of ALS patients classified on their clinical
signs and MRI diagnostic features. It was hypothesized that the degree of brain WM
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degeneration in ALS would depend on the disease type.
1.6.2. Objective
The overall objective of this thesis was to apply FD analysis to understand
morphological adaptations of brain WM structure afflicted by ALS. Specifically, a large
group of ALS patients were categorized into four subgroups according to the clinical
symptoms and conventional MRI results; the degree of WM degeneration was assessed in
each of and compared among the four ALS patient groups. Three dimensional (3D) FD
analysis was performed to understand three forms of brain WM structures in ALS:
skeleton - interior structure, surface - interface structure between GM and WM, and
general structure – the entire shape of WM (it partly reflects the volume of WM). The
combination of these three forms structural analyses in classified ALS groups provided a
comprehensive characterization of brain WM structural adaptations caused by different
ALS phenotypes.
1.6.3. Specific Aims
Aim 1 – To evaluate FD of brain WM structure to determine its complexity level
and compare the WM structural complexity among four groups of ALS patients.
Hypothesis 1 – The level of the WM structural complexity would be the lowest in
ALS patients with dementia.
Aim 2 – To compare FD values among three forms of brain WM structure, skeleton,
surface and general structure.
Hypothesis 2 – FD measurement of the skeleton would be the most sensitive
variable among the three in detecting brain WM degeneration in a given ALS patient
group.
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Aim 3 – To determine whether the complexity level of brain WM structure was
symmetrical between left and right hemispheres and whether assessing the whole brain
was more sensitive in detecting the WM structure degeneration than analyzing each
individual hemisphere.
Hypothesis 3 – The level of brain WM structural complexity would be
asymmetrical in some type of ALS patients but not all; FD measurement of the whole
brain WM would be more sensitive than that of each individual hemisphere in finding
significant brain WM structural changes.
1.6.4. Thesis Organization
Chapter 1: Introduction and Background
This chapter introduces general background of the nervous system and ALS;
provides an overview of neuroanatomy, especially WM anatomy; and describes concepts
of skeleton and fractal dimension. The overall objective and specific aims, and
organization of the thesis are stated at the end of the chapter.
Chapter 2: Materials and Methods
This chapter explains the study subjects and classification of ALS subgroups; MRI
data (image) acquisition; and image processing, WM extraction and FD analysis.
Chapter 3: Results
This chapter reports FD (WM structure complexity) comparison results among
ALS subgroups and between ALS and healthy controls within same hemispheres,
between two hemispheres, and in the whole brain.
Chapter 4: Discussion
This chapter discusses main findings of this research, points future directions, and
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acknowledges limitations of the current study.
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CHAPTER II

MATERIALS AND METHODS

2.1. Subjects
A total of 100 subjects participated in the study and they were assigned into (1) a
neurological control group (N=11, 51.7 ± 16.6 yrs, 3 females) and four patient groups
according to their clinical signs and conventional MRI results: (2) 20 ALS patients with
co-existing frontotemporal dementia (ALS-FTD group, 66.7 ± 9.9 yrs, 13 females), (3)
20 UMN-predominant ALS patients with CST hyperintensities (UMN-CST+ group; 52.9
± 11.5 yrs, 7 females), (4) 27 UMN-predominant ALS patients without CST
hyperintensities (UMN-CST- group; 59.7 ± 11.9 yrs, 12 females), and (5) 22 classic ALS
patients with an equal amount of UMN and LMN signs (ALS-classic group; 57.4 ± 11.5
yrs, 10 females). We were not the first to classify ALS patients based on their clinical
signs. Cheung et al. divided ALS patients into three ALS subgroups based upon the UMN
and LMN signs: (i) classic ALS, in which both UMNs and LMNs were affected; (ii)
upper motor neuron type or primary lateral sclerosis, in which only central motor neurons
(UMNs) were affected; and (iii) lower motor type or primary muscular atrophy, in which
only LMNs were affected (Cheung et al., 1995). Some of the control subjects had
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neurological disorders, such as Parkinson’s disease and long-term headache. All the
T1-weighted MRI data were obtained by a 1.5T scanner as routine clinical imaging data
for patient evaluation. The Institutional Review Board at the Cleveland Clinic approved
storage and de-identification of the images as part of the “Neuroimaging
Registry/Database for CNS Analysis in Patients with Motor Neuron Disease”.

2.2. Collection of MR Head Images
The 3D coronal MRI brain images of the whole cerebrum were obtained using a
1.5T Siemens Symphony (Erlangen, Germany) scanner by a process known as the
magnetization prepared rapid gradient echo (MPRAGE) sequence. The following
MPRAGE parameters were used for the image acquisition.
Parameter

Value

Slice Thickness

1 [mm]

Number of Slices

160

TR

1800 [ms]

TE

4.38 [ms]

TI

1100 [ms]

Flip Angle

10 [deg]

In-plate Resolution

1×1 [mm2]

2.3. Image Processing
Figure 5 shows the steps involved in processing the coronal MRI brain images.
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Figure 5: Image processing flowchart

2.3.1. Brain Extraction
The brain extraction step was processed using the Brain Extraction Tool (BET) in
the FMRIB Software Library (FSL) package (Analysis Group, Center for Functional
Magnetic Resonance Imaging of the Brain (FMRIB), Oxford, UK). The BET extracts the
brain from the whole head image by removing non-brain tissue. There are currently three
main methods to segment the brain tissue from the non-brain tissue: manual segmentation
method, thresholding-with-morphology method, and surface model-based method. The
BET basically uses deformable surface models which consist of a tessellated mesh of
triangles. First, the centre-of gravity of the head image was found according to the
intensity histogram. Then, a triangular tessellation of a sphere’s surface was located
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inside the head based on the pre-defined centre of gravity. Finally, the tessellation slowly
deformed to the edge of the brain tissue by iteratively updating each vertex to surface
until the final tessellated surface was self-intersecting. The surface of extracted brain was
kept well spaced and smooth. Otherwise, the whole process would be repeated with a
higher smoothness constraint (Smith, 2002).
2.3.2. Brain Tissue Segmentation (WM/GM/CSF)
The brain tissue segmentation step was carried out using FMRIB’s Automated
Segmentation Tool (FAST) in the FSL package. The extracted brain images from the BET
were processed to produce three separate images: WM, GM, and corticospinal fluid
(CSF). FAST is a statistical segmentation approach that generates an image with voxels
of varying intensity that represent the proportion of each specific tissue present. During
FAST, the bias field (intensity inhomogeneities in the RF field) was estimated and
removed from the extracted brain images to prevent the intensity variations. To correct
any spatial intensity variation, an algorithm presented by Guillemaud and Brady is used
to facilitate segmentation. Lastly, the hidden Markov random field (HMRF) model was
applied to encode the spatial information through the mutual influences of neighboring
sites (Zhang et al., 2001).
2.3.3. Obtaining Skeleton
A 3D thinning method was applied to the binary images in order to obtain the
skeleton (Ma and Sonka, 1996). A set of deleting templates (which are position
configuration of object voxels and background voxels in a 3×3×3 window) were designed
to determine whether the boundary voxels should be removed. This approach eliminated
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every parallel object voxel, satisfying at least one deleting template until no voxel could
be deleted.
2.3.4. Separation of Left and Right Hemisphere
The hemispheres separation step was performed with the FSL FLIRT (FMRIB’s
Linear Image Registration Tool), which is an accurate and robust affine registration tool.
The Montreal Neurological Institute (MNI) structural atlas (Jack Lancaster, Research
Imaging Center, UTHSCSA, Texas) was also involved in the separation.
First, an affine matrix was calculated by registering the MNI 152 template to each
brain image. Then, the left and right halves of the MNI brain were separated and
transformed into subject space by applying the affine matrix to create hemisphere brain
masks. Next, each hemisphere mask was multiplied with tissue images or skeleton
images to produce a hemisphere of specific tissue or skeleton tissue (e.g. multiplying the
left hemisphere mask with WM produced the left hemisphere of WM). Finally the
hemisphere tissue images were saved as binary (black-and-white) images.
Figure 6 demonstrates the image processing results based on one sample slice from
a control subject (Figure 6A, C, E) and one sample slice from an ALS-FTD subject
(Figure 6B, D, F). The WM segmentation results indicated that the FAST method
segmented WM of the brain well (see Fig legend for details).
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Figure 6: Image processing results based on one sample slice from one control subject (A,C,E) and one
sample slice from one ALS-FTD subject (B,D,F). Images on left column are the processing results for the
control subject: (A) T1-weighted head image; (C) Brain extraction result; (E) Brain tissues and WM
skeleton overlaid onto the original head image. Images on right column are the processing results for the
ALS-FTD subject: (B) T1-weighted head image; (D) Brain extraction result; (F) Brain tissues and WM
skeleton overlaid onto the original head image.

2.4. Fractal Analysis
In general, FD serves as an index of morphometric variability and complexity of an
object. A higher FD value refers to a more complicated structure. There are three forms of
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FDs in this study: skeleton FD, surface FD, and the general structure FD. The skeleton
FD and the surface FD serve as the index to detect the interior structure and surface
degeneration respectively. The general structure FD is the index to assess the WM
atrophy. Because the skeleton physiologically represents the complexity of the WM fiber
bundle connectivity network (e.g. fiber crossing, bifurcation), a declined skeleton FD
means the degeneration of WM fibers. The surface is the interface between the GM and
WM, representing the facial convolution, therefore a lower surface FD means a smoother
facial structure. A reduced general structure FD tells that WM volume decreased.
The 3D box-counting method derived from the Harmonic and Fractal Image
Analyzer (HarFA) was applied to calculation of the fractal dimension of defined structure
(Zhang et al., 2006). The entire process consists of three major steps: (i) counting the
number of boxes covering the skeleton or WM structure; (ii) performing linear regression
analysis to obtain the slope value, which was the initial FD; and (iii) performing single
slope analysis to get the accurate FD. In the third step, different thresholds were applied
to improve accuracy of FD calculation.
Using the HarFA counting mechanism, the image was divided into three different
parts after applying the box-mesh: the background, the object and the boundary of the
object. The HarFA counted three categories of boxes belonging to those three separate
areas: (i) NB, which covered only the black background; (ii) NW, which contained only
the object area; and (iii) NBW, which covered the border of object and contained part of
the white object and part of the black background (Figure 7). As a result, there were three
different FDs (FDB, FDW, FDBW correlated with NB, NW and NBW respectively)
representing the properties of the black background, the white object, and the boundary
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of the object. The traditional box-counting dimension was FD WBW which was determined
by the sum of NW and NBW (NWBW).

(A)

(B)

Figure 7: 2D box-counting method in HarFA. Mesh with different-sized boxes (r) was put to cover the 2D
sample binary WM slice. Number of boxes (NW) which cover the object WM ( green boxes), number of
boxes (NB) which cover the black background (blue boxes) and number of boxes (NBW) which cover the
boundary between WM and black background (rest boxes). The images were generated by the box-counting
package from HarFA (http://www.fch.vutbr.cz/lectures/imagesci/) using data from one subject.
(A) r=5 pixels, NW=557, NB=2688.3157, NBW=729; (B) r=15 pixels, NW=17, NB=244.5911, NBW=180.

2.5. Statistical Analysis
A one-way analysis of variance (ANOVA) (control vs. ALS-FTD vs. UMN-CST+
vs. UMN-CST- vs. ALS-classic groups) was conducted to analyze the WM structure of
the whole brain to determine the disease effects on the WM FDs. A two-way repeated
measures ANOVA (within factor, left vs. right hemispheres; between factor, control vs.
ALS-FTD vs. UMN-CST+ vs. UMN-CST- vs. ALS-classic groups) was performed
separately to detect the left-right hemispheric asymmetry of the WM structure in each
group and compare that information among the groups. Significant differences were
accepted at P ≤ 0.05. Generalized linear model was used to fit the one-way or two-way
ANOVA in this study. The type III F-statistics and p-values were calculated based on the
F statistics. Spearman’s rank correlation coefficient analysis was carried out to determine
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the relationship between scores of ALS function evaluation and FD of brain WM
structures.
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CHAPTER III

RESULTS

Fractal dimension (FD) of white matter (WM) of each hemisphere as well as the
entire brain was evaluated on three separate structural forms: skeleton, surface, and
general structure. The WM skeleton represents the interior structure patterns and reveals
paths of WM tracts that contain axons of neurons connecting different neural populations.
The WM surface is the facial convolution pattern of the system. The WM general
structure refers to the entire shape patterns. The results of three forms of WM FDs were
shown in the Table I.

3.1. Disease Effect on WM Structure Changes
Comparisons of FD values of the three WM structural forms were made in each
hemisphere and the whole brain among the ALS subgroups. FD differences in WM
skeleton, surface, and general structure of the left or right hemisphere by post hoc tests
and those of whole WM by one-way analysis of variance (ANOVA) among the ALS
subgroups are shown in Figures 8-10 and Tables II-IV. In all figures, each bar graph is the
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FD mean in a given group and the corresponding error bar refers to standard deviation of
the mean.
3.1.1. WM Interior (Skeleton) Structure Complex
With respect to skeleton, the UMN-CST+ group has the most complex interior
pattern while the ALS-FTD group has the simplest interior structure. The FD of the WM
skeleton in the left hemisphere was significantly greater in the UMN-CST+ group when
compared with the ALS-FTD group (P=0.033) and the UMN-CST- group (P=0.043)
(Figure 8A). The WM skeleton FD in the right hemisphere was markedly greater in the
UMN-CST+ group than the other ALS groups with P<0.001 (compared with ALS-FTD),
P=0.005 (with UMN-CST-), and P=0.024 (with ALS-classic) (Figure 9A). When the
whole brain WM skeletons were compared among the groups, significant differences
were observed between the control and ALS-FTD (P=0.028), ALS-FTD and UMN-CST+
(P<0.001), ALS-FTD and ALS-classic (P=0.024), UMN-CST+ and UMN-CST(P=0.001), and UMN-CST+ and ALS-classic (P=0.013) (Figure 10A). The WM skeleton
FD data show different complexity patterns among the studied groups.
3.1.2. WM Surface (Convolution Pattern) Complexity
FD in the WM surface had no significant differences among the five groups in both
left and right hemispheres (Figure 8B and 9B). The WM surface FD for the whole brain
was greater only in the ALS-classic group when compared to the UMN-CST- group
(P=0.049) (Figure 10B). These results suggest that the complexity of WM surface
structure was almost the same among all five groups with exception of more complicated
surface structure between the ALS-classic and the UMN-CST- groups.
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3.1.3. WM General Structure Complexity
The UMN-CST+ group exhibited significantly greater WM general structure
complexity than the UMN-CST - group when both the right hemisphere (P=0.019) and the
whole brain (P=0.004) were compared (Figure 9C and 10C). FD of the WM general
structure for the whole brain was also greater in the UMN-CST+ than the ALS-classic
(P=0.045) groups. FD of the WM general structure for the whole brain was significantly
smaller in the ALS-FTD group than the control (P=0.008), UMN-CST+ (P<0.001) as well
as the ALS-classic (P=0.021) groups. In general, the WM general structure complexity
showed remarkable changes among the groups only in the whole brain with the least FD
reduction in the UMN-CST+ group and the greatest reduction in the ALS-FTD group.
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Table I: Results of white matter fractal dimension
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Figure 8: Left hemisphere WM FD results of five groups. (A) skeleton, (B) surface, and (C) general
structure. *P<0.05, **P<0.01
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Figure 9: Right hemisphere WM FD results of five groups. (A) skeleton, (B) surface, and (C) general
structure. *P<0.05, **P<0.01
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Figure 10: Whole brain WM FD results of the five groups. (A) skeleton, (B) surface, and (C) general
structure. *P<0.05, **P<0.01
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Table II: Two-way repeated measures ANOVA P value on white matter fractal dimension between groups
in left hemisphere skeleton, surface, and general structure
Group
Skeleton
Surface
General Structure

Control
ALS-FTD

LS means

SE

LS means

SE

LS means

SE

2.407

0.007

2.462

0.005

2.582

0.012

2.404

0.005

2.468

0.004

2.572

0.009

+

2.420

0.005

2.467

0.004

2.590

0.009

UMN-CST-

2.406

0.005

2.464

0.003

2.582

0.008

ALS-classic

2.412

0.005

2.471

0.004

2.591

0.009

F value

1.36

0.83

0.64

P value

0.254

0.509

0.633

UMN-CST

SE=standard error, LS means=least squares means (*P<0.05, **P<0.01)
Table III: Two-way repeated measures ANOVA P value on white matter fractal dimension between groups
in right hemisphere skeleton, surface, and general structure
Group
Skeleton
Surface
General Structure

Control
ALS-FTD

LS means

SE

LS means

SE

LS means

SE

2.409

0.007

2.467

0.005

2.598

0.012

2.394

0.005

2.465

0.004

2.583

0.009

+

2.420

0.005

2.472

0.004

2.603

0.009

UMN-CST-

2.400

0.005

2.465

0.003

2.575

0.008

ALS-classic

2.404

0.005

2.468

0.004

2.581

0.009

F value

4.00

0.47

1.99

P value

0.005**

0.759

0.102

UMN-CST

SE=standard error, LS means=least squares means (*P<0.05, **P<0.01)
Table IV: One-way ANOVA P value on white matter fractal dimension between groups in whole brain
white matter skeleton, surface, and general structure
Group
Skeleton
Surface
General Structure

Control
ALS-FTD

LS means

SE

LS means

SE

LS means

SE

2.487

0.006

2.549

0.005

2.633

0.004

2.469

0.005

2.551

0.004

2.618

0.003

+

2.501

0.005

2.557

0.004

2.638

0.003

UMN-CST-

2.480

0.004

2.547

0.003

2.625

0.003

ALS-classic

2.484

0.004

2.557

0.004

2.629

0.003

F value

5.86

1.56

5.15

P value

<0.001**

0.191

0.001**

UMN-CST

SE=standard error, LS means=least squares means (*P<0.05, **P<0.01)
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3.2. Asymmetry of WM Structure Complexity between Left and Right Hemispheres
The WM structural complexity between the two hemispheres was analyzed using
repeated measures ANOVA. In general, the structural complexity was symmetrical in all
groups except that the skeleton FD was significantly smaller (P<0.05) for right than left
hemispheres in ALS-FTD and ALS-classic groups (Figure 11 A, B, and C). This indicates
that only the interior WM structure (skeleton) was asymmetrical between the hemispheres
in only ALS-FTD and ALS-classic groups. The actual FD values for between-hemisphere
comparisons among the groups are shown in Table V (skeleton), Table VI (surface) and
Table VII (general structure).
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Figure 11: Histogram of WM FD results in left and right hemispheres for the (A) skeleton, (B) surface, and
(C) general structure
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Table V: Results of two-way repeated measures ANOVA for hemispheric WM skeleton FD comparisons
Left Hemisphere
Right Hemisphere
Group
t value
P value
LS means
SE
LS means
SE
Control
ALS-FTD

2.407

0.007

2.409

0.007

-0.21

0.837

2.404

0.005

2.394

0.005

2.27

0.025*

UMN-CST

+

2.420

0.005

2.420

0.005

0.02

0.982

UMN-CST

-

2.406

0.005

2.400

0.005

1.50

0.138

ALS-classic

2.412

0.005

2.404

0.005

2.05

0.043*

SE=standard error, LS means=least squares means (*P<0.05, **P<0.01)

Table VI: Results of two-way repeated measures ANOVA for hemispheric WM surface FD comparisons
Left Hemisphere
Right Hemisphere
Group
t value
P value
LS means
SE
LS means
SE
Control
ALS-FTD

2.462

0.005

2.467

0.005

-1.26

0.209

2.468

0.004

2.465

0.004

1.11

0.271

+

2.467

0.004

2.472

0.004

-1.60

0.112

UMN-CST-

2.464

0.003

2.465

0.003

-0.54

0.594

ALS-classic

2.471

0.004

2.468

0.004

1.25

0.214

UMN-CST

SE=standard error, LS means=least squares means (*P<0.05, **P<0.01)

Table VII: Results of two-way repeated measures ANOVA for hemispheric WM general structure FD
comparisons
Left Hemisphere
Right Hemisphere
Group
t value
P value
LS means
SE
LS means
SE
Control

2.582

0.012

2.598

0.012

-1.28

0.202

ALS-FTD

2.572

0.009

2.583

0.009

-1.24

0.216

UMN-CST+

2.590

0.009

2.603

0.009

-1.44

0.154

-

2.582

0.008

2.575

0.008

0.89

0.374

ALS-classic

2.591

0.009

2.581

0.009

1.11

0.271

UMN-CST

SE=Standard Error, LS means=Least Squares Means (*P<0.05, **P<0.01)
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CHAPTER IV

DISCUSSION

The main findings of this were that (i) ALS patients with dementia (ALS-FTD) had
greatest brain WM degeneration (showing by FD-measured WM structural complexity)
among the four ALS groups, as well as compared with the control group. (ii) ALS
patients without hyperintensity signals in the CST (UMN-CST-) exhibited second worst
WM structural degeneration among the analyzed groups, followed by patients with
classic ALS signs (ALS-classic). (iii) Brain WM structure was least affected in ALS
patients with hyperintensity signals in the CST (UMN-CST+) among the four ALS groups,
which was comparable with and many times even slightly better than the WM structure
of the control group. (iv) Among the three forms of brain WM structure measured,
skeleton seemed to be the most sensitive form fro detecting WM structural degeneration
followed by general structure and surface. (v) FD structural analysis in the whole brain
was more sensitive than in a single hemisphere in detecting brain WM structural
degeneration. (vi) Brain WM structure complexity indicated by skeleton FD was
asymmetrical in the ALS-FTD and ALS-classic groups with a higher complexity measure
for the left hemisphere. These results are discussed below.
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4.1. WM of ALS-FTD Patients
The ALS-FTD group showed significant decreases in FD of the left and right
hemisphere skeleton compared with UMN-CST+ group and in FD of the whole brain
skeleton compared with control, UMN-CST+, and ALS-classic groups. For the general
structure, ALS-FTD patients had significantly reduced FD of the whole brain relative to
the control, UMN-CST+, and ALS-classic groups. No difference in FD of surface
structure between ALS-FTD and any of other groups (Figures 8-10).
Although patients in ALS-FTD group have symptoms of both ALS and FTD, it is
believed that FTD is the main cause of the observed decline of skeleton and general
structure FD measures. Since the FD measurements of WM is determined by the
complexity level of the brain WM fiber bundle connectivity network (such as fiber
crossings and bifurcations), the decreased FD of the WM structure, especially skeleton
structure, indicates a weakened connectivity in the WM network. A significant reduction
in brain WM structural complexity level in ALS-FTD patients may be a consequence of
WM loss (Boxer et al., 2010) as a result of GM loss throughout the frontal and temporal
lobes in ALS-FTD patients (Rajagopalan, 2010). GM loss along with abnormal
diffusivity in WM tracts connecting the affected GM regions contributed to the damage
of neuronal network in white matter, particularly in the fontal and temporal lobes
(Whitwell et al., 2010).
Although some of the control subjects suffered other neurological diseases such as
Parkinson’s disease and chronic headache, this group on average, did not have GM or
WM atrophy in the frontal and temporal lobes and the WM fiber bundle connectivity
network was not afflicted remarkably. This was also true for the UMN-CST+ group
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(Rajagopalan, 2010). In that case, the skeleton FD and general structure FD of control
and UMN-CST+ groups were higher than those of the ALS-FTD group.
Figure 12 shows 2D images of WM skeletons of a control (left), ALS-FTD
(middle), and UMN-CST+ (right) subject in each row of images (upper row: horizontal
plane, lower row: coronal plane). The extracted 2D skeletons, colored in yellow, are
overlaid onto the corresponding T1-weighted head images. These skeleton images show
inner structure of the WM system. It is clear from the 2D WM images on both horizontal
and coronal planes that the skeletons of the ALS-FTD patient are distributed loosely and
have fewer branches compared those of the control subject and UMN-CST+ patient.
This would indicate a lower level of WM structural complexity level in ALS-FTD than
other two subjects.

Figure 12: Illustration of 2D WM skeletons in two planes: horizontal plane (upper row) and coronal plane
(lower row). In each row, an image of a control (left), ALS-FTD (middle), and UMN-CST+ (right) subject
is displayed. The ALS-FTD patient shows the lowest complexity level in the WM skeleton structure among
the three subjects.
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Images in Figure 13 show WM structural differences among the three subjects by
qualitative comparisons of non-GM and non-WM areas. In each image, light blue areas
represent GM and dark blue (right hemisphere) and red (left hemisphere) areas show WM
tissues. It is clear that the ALS-FTD patient (middle image in each row) is with
noticeably larger non-brain tissue areas than either the control (left image) or UMN-CST+
(right image) subject, especially the gap between the two hemispheres. The increased
non-brain tissue areas in ALS-FTD may be related to a decline in WM structure
complexity level in this group of patients.

Figure 13: Illustration of the left (red) and right (blue) hemisphere WM in horizontal (upper row) and
coronal (lower row) planes of a control (left image in each row), ALS-FTD (middle image), and
UMN-CST+ (right image) subject. Light blue color areas represent GM. The ALS-FTD patient exhibits
larger non-brain tissue areas.

4.2. WM of UMN-CST+ Patients
ALS patients in UMN-CST+ group showed higher FD measures in WM skeleton
structure than all other three ALS subgroups in each hemisphere (except ALS-classic
group in left hemisphere) as well as the whole brain. For the WM general structure, the
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UMN-CST+ group had higher FD values in the whole brain than all other three ALS
subgroups, and than UMN-CST- group in the right hemisphere. These findings suggest
that complexity of the interior and general WM structures of UMN-CST+ patients was
less affected than the other ALS groups.
Although it has been suggested that the mechanism of hyperintensity along the
CST is either the result of Wallerian degeneration (Prodan and Holland, 2002) or due to a
dying back process (Lee et al., 2003), the exact cause of the hyperintensity is still
unknown. Even less is known of why ALS patients with CST hyperintensity do not
experience as much changes in brain WM structural complexity than other ALS patient
groups. It could be related to differences in the degree of nerve degeneration or the rate of
nerve regeneration among various types of ALS disease.
Because ALS is a progressively degenerative disorder, the degeneration gets worse
with duration of ALS symptoms. Figure 14 shows that ALS patients in UMN-CST+ group
have a significantly shorter duration of symptoms than the UMN-CST- and ALS-classic
groups (P < 0.001 and 0.016, respectively). Consistent with the results of this, the degree
of degeneration in the WM structure complexity of these two groups was more severe
than the UMN-CST+ group. As a result, by comparing two groups of ALS patients with
predominant UMN signs with and without CST hyperintensity, less affected WM
structure in UMN-CST+ patients could probably be related to their short duration of the
symptoms. Also, a significantly shorter duration of symptoms in ALS-classic group than
that in UMN-CST- group (P < 0.05) was found, which could explain the reason of why
the ALS-classic group has a more complicated surface than UMN-CST- group.
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Figure 14: Comparison of symptom duration among UMN-CST+, UMN-CST- and ALS-classic groups.
Patients in UMN-CST+ group had shortest symptom duration.

Regeneration occurs in both the central nervous system (CNS) and peripheral
nervous system (PNS), even in ALS and can rectify or slow down, to a certain degree the
degeneration process (Hilliard, 2009). Neuroregeneration in the PNS occurs to a
significant degree (Yiu and He, 2006), while injury to the CNS is not followed by
extensive regeneration. In PNS, axonal sprouts from at the proximal segment grow until
they enter the distal segment, and the growth is governed by chemotactic factors secreted
from Schwann cells or neurolemmocyte. In CNS, regeneration is limited by the inhibitory
influences of the glial and extracellular environment. For example glial scars actually
produce factors that inhibit remyelination and axon repair (Yiu and He, 2006; Karnezis et
al., 2004; Bregman et al., 1995). After the recovery of the axon, the fiber could
reinnervate the original target muscle to restore original functionality. To summarize,
both UMN and LMN regeneration rates are controlled by some other factors (e.g.
chemotactic factors, glial scars).
In ALS, Nogo-A is a key factor in restricting regeneration and repair of injured
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axons, which increases the regulation level by a reduced expression of Nogo-A
(GrandPre et al., 2002; Jokic et al., 2006; Karnezis et al., 2004). The regeneration rates
and degree of nervous system recoveries of different ALS subgroups may diverge due to
differences in the control factors (e.g. expression level of Nogo-A). Furthermore, more
fatty tissue (e.g. myelin) is indicated by hyperintensity in T2-weighted images, meaning
the hyperintensity along CST probably represents fiber remyelination and axon
regeneration. If so, it is logic to see the UMN-CST+ group to have a relatively more
complex WM connectivity network compared with the other ALS patient subgroups. The
results of the research presented here agree with this assumption.

Figure 15: Illustration of 2D WM skeletons (upper row) and left (red) and right (blue) hemispheres of WM
in horizontal plane in a UMN-CST+ (left image in each row), UMN-CST- (middle image),and ALS-classic
(right image) subject. The skeleton structure shows a more complex pattern in UMN-CST+ than
UMN-CST- and ALS-classic groups.
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In 2D skeleton images (Figure 15), one can deduce that WM skeletons of the
UMN-CST+ subject (upper row, left image) is more tightly packed than the UMN-CST(middle image) and ALS-classic (right image) groups. As a result, the WM interior
structure shows a more complex pattern than the other two groups.
Images in lower row in Figure 15 indicate that the volume of WM (blue and red
colors) is larger in UMN-CST+ patient (left Image) than UMN-CST- (middle image) and
ALS-classic (right image) patient.
4.3. Correlation between ALSFRS-R Scores and FDs
Amyotrophic lateral sclerosis functional rating scale revised (ALSFRS-R) is a
standardized score indicating functional status of ALS patients. It scales the total
functional disability with a range from 0 (maximum disability) to 48 (normal) points. It is
a widely-used tool for evaluation of functional status and disease progression in ALS
patients.
By calculating the Spearman’s rank correlation coefficient (rs) for the skeleton FD,
surface FD, and general structure FD with the ALSFRS-R scores, it was found that the
FDs increase with the ALSFRS-R score. A correlation coefficient of 0.42 (P = 0.0001,
Figure 16A) was found between the skeleton FD, 0.40 between the surface FD and
ALSFRS-R (P = 0.0002), Figure 16B), and 0.38 between general structure FD and
ALSFRS-R (P = 0.0004, Figure 16C).
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Figure 16: Correlation graphs showing Spearman’s rank correlation coefficient (r s) between ALSFRS-R
scores and FDs of skeleton (A, r s =0.42, P=0.0001), surface (B, r s =0.40, P=0.0002), and general (C, r s
=0.38, P=0.0004).
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The positive correlation between ALSFRS-R scores and the FDs indicates that ALS
patients with better function status have a more complicated structure in all the interior,
surface, and general shapes of brain WM structure. A positive correlation between the FA
of the CST and ALSFRS-R score has been found to suggest that a low ALSFRS-R score
reflects a loss of fiber connectivity and axonal degeneration (Thivard et al., 2007). A
decrease in DTI FA (fractional anisotropy) would confirm a loss of fiber integrity by
axonal degeneration. The data presented in this thesis finds the same conclusion.
4.4. Hemispheric Asymmetry in Brain WM of ALS Patients
The WM complexity asymmetry could be function-related and reflect influences
from disease. In health people, the complexity of WM surface convolution was
symmetrical between hemispheres and the complexity of the interior and general
structures had a rightward asymmetry (Zhang et al., 2007). In this study, the data revealed
that WM had leftward complexity asymmetry pattern in the interior (skeleton) structure
of the ALS-FTD and the ALS-classic patients, suggesting that WM degeneration may be
more severe in the right hemisphere than in the left hemisphere for those two subgroups.
The predominantly right-sided FTD patients (the FTD patients with predominantly
right hemisphere degeneration) are marked with some behavioral alteration (e.g. poor
impulse control, childish) (Mychack et al., 2001). The right hemisphere is dominant in
both the comprehension and expression of emotion (e.g. speech intonation, body
gesturing) (Tucker et al., 1995). In that case, the FTD patients, who suffer more damage
on the right than the left hemisphere, may show deficits in the interpretation of facial
expressions (Borod et al., 1985), bizarre expression of affect (Mychack et al., 2001) and
other disabilities.
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4.5 Limitations and Future Directions
The images used in this study were clinical evaluation images that were not
acquired specifically for research purposes.

Therefore, the quality of the images could

have been better such as collected with a 3T scanner. Some of the control subjects were
not true healthy controls and this might have affected the measured values of this group
and results of comparisons with patient groups. Volumetric measurements of grey and
white matter of the brain were not compared with FD results in the patient groups. Future
studies should correct these limitations. In addition, future research should correlate FD
measures of WM structure complexity with DTI evaluation of WM integrity to better
understand mechanisms of WM degeneration in ALS. Longitudinal evaluations of brain
grey and white matters and cognitive and sensorimotor functions of ALS patients would
provide critical information for understanding the disease progression and for seeking
effective treatments.

4.6 Conclusion
ALS patients with frontal-temporal lobe dementia have greatest brain white matter
structural degeneration among ALS patients with different clinical signs. Grey matter loss
in the frontal and temporal lobes could be the primary cause of the white matter
degeneration in this category of patients. Brain WM structure is least affected in ALS
patients with corticospinal tract hyperintensity signals among the classified ALS
subgroups. This may be due to the fact that this group of patients experience the shortest
ALS symptom duration. The level of WM structure degeneration in ALS is patient-type
dependent. Fractal dimension measurement of the white matter structural complexity
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correlates significantly with widely used clinical score of amyotrophic lateral sclerosis
functional rating scale revised, suggesting that the structural measurement reflects
functionality of the patients. Among the three forms of brain WM structure measured,
skeleton is the most sensitive substructure for detecting WM structural degeneration in
ALS patients. FD structural analysis in the whole brain was more sensitive than in a
single hemisphere in detecting brain WM structural degeneration in ALS. Brain WM
structure complexity is asymmetrical in ALS patients with dementia and ALS with an
equal amount of upper and lower motor neuron signs.
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